What Is GHK-Cu?
GHK-Cu is a naturally occurring copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys). It was first identified by Dr. Loren Pickart in 1973 during studies investigating why liver tissue from young individuals could stimulate old liver tissue to synthesize proteins at a more youthful rate. Pickart isolated the active factor from human plasma and determined it to be a copper-binding tripeptide. GHK-Cu has a molecular weight of approximately 403.9 Da (peptide alone) or approximately 466.0 Da (copper complex).
Circulating GHK-Cu concentrations decline significantly with age: from approximately 200 ng/mL in plasma at age 20 to approximately 80 ng/mL by age 60, a reduction of roughly 60%. This age-related decline parallels many of the tissue repair and regenerative deficits associated with aging, leading to the hypothesis that declining GHK-Cu levels contribute to impaired wound healing, reduced collagen production, and other age-related tissue changes.
GHK-Cu has become one of the most studied peptides in tissue remodeling research, with published work spanning wound healing, skin biology, hair follicle biology, bone repair, lung fibrosis, and neuroprotection. Its ability to modulate the expression of over 4,000 human genes makes it one of the most broadly active regulatory peptides known.
Mechanism of Action
GHK-Cu operates through multiple interconnected mechanisms, with copper delivery and gene expression modulation being the most extensively characterized.
Copper Delivery and Metalloenzyme Activation. The tripeptide GHK has a high binding affinity for copper(II) ions (stability constant approximately 10^14), making it an efficient copper transport molecule. Copper is an essential cofactor for several enzymes critical to tissue structure and function. Lysyl oxidase requires copper to catalyze the cross-linking of collagen and elastin fibers — the covalent bonds that give connective tissue its tensile strength and elastic resilience. Superoxide dismutase 1 (SOD1), the primary cytoplasmic antioxidant enzyme, requires copper and zinc at its active site to catalyze the dismutation of superoxide radicals to hydrogen peroxide and oxygen. Cytochrome c oxidase (Complex IV), the terminal enzyme of the mitochondrial electron transport chain, requires copper for electron transfer and ATP production. By delivering copper to these metalloenzymes, GHK-Cu supports their activity in tissues where copper availability may be limiting, particularly in aged or damaged tissues.
Broad Gene Expression Modulation. Perhaps the most remarkable property of GHK-Cu is its ability to modulate the expression of approximately 4,000 human genes, representing roughly 6% of the human genome. This was demonstrated through comprehensive gene expression profiling (microarray and RNA-seq studies) comparing GHK-treated and untreated human cells. The pattern of gene expression changes is striking in its coherence: GHK-Cu consistently upregulates genes associated with tissue repair, stem cell differentiation, antioxidant defense, and anti-inflammatory responses, while simultaneously downregulating genes associated with tissue destruction (matrix metalloproteinases, inflammatory cytokines), fibrosis, and cellular senescence.
Specific gene expression effects include upregulation of DNA repair enzymes (including components of the base excision repair and mismatch repair pathways), anti-apoptotic genes (Bcl-2 family members), ubiquitin-proteasome system components (promoting clearance of damaged proteins), and stem cell markers (suggesting activation of tissue-resident stem/progenitor cells). Downregulated genes include pro-inflammatory mediators, pro-fibrotic growth factors (particularly TGF-beta isoforms), and matrix-degrading enzymes.
Extracellular Matrix Remodeling. GHK-Cu stimulates the synthesis of multiple extracellular matrix (ECM) components, including collagen types I, III, and V, elastin, proteoglycans, and glycosaminoglycans (GAGs) such as hyaluronic acid and dermatan sulfate. Simultaneously, it regulates matrix metalloproteinase (MMP) activity — not simply inhibiting MMPs, but modulating the balance between MMPs and their tissue inhibitors (TIMPs) to promote organized matrix turnover rather than destructive degradation. This coordinated regulation of ECM synthesis and remodeling is critical for producing functional tissue repair rather than disorganized scar formation.
Anti-Inflammatory Activity. GHK-Cu suppresses the production of key pro-inflammatory mediators including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta (TGF-beta). It also modulates the NF-kB inflammatory signaling pathway. These anti-inflammatory effects help resolve the inflammatory phase of wound healing and prevent the chronic inflammation that impairs repair in aged tissues and chronic wounds.
Skin and Wound Healing Research
The most extensive body of GHK-Cu research concerns its effects on skin biology and wound healing.
Collagen and ECM Production. In human dermal fibroblast cultures, GHK-Cu significantly increases the production of collagen I and III, the predominant structural collagens of skin. It also enhances elastin production, proteoglycan synthesis, and GAG accumulation. The combination of increased collagen and elastin production with improved cross-linking (via lysyl oxidase activation) produces ECM with superior structural and mechanical properties.
Wound Healing. In animal wound models, GHK-Cu has demonstrated accelerated wound closure rates, enhanced granulation tissue formation, increased angiogenesis (new blood vessel formation at the wound site), and improved tensile strength of healed tissue. These effects are consistent with its multi-faceted mechanism involving copper delivery, growth factor modulation, ECM stimulation, and anti-inflammatory activity.
Antioxidant Defense. By activating SOD and by upregulating other antioxidant enzymes through gene expression modulation, GHK-Cu enhances the skin's defense against reactive oxygen species (ROS). This is particularly relevant to photoaged skin, where chronic UV exposure generates oxidative damage that degrades collagen and elastin.
Hair Follicle Research. In mouse models, GHK-Cu has demonstrated the ability to enlarge hair follicles, stimulate hair growth, and enhance follicle cycling. The proposed mechanism involves activation of follicular stem cells, increased dermal papilla cell proliferation, and Wnt/beta-catenin pathway modulation.
Research Beyond Skin
While skin and wound healing represent the primary evidence base, GHK-Cu's broad gene expression effects suggest applications across multiple tissue types.
Bone Repair. GHK-Cu demonstrates osteogenic properties in vitro, promoting osteoblast differentiation, increasing alkaline phosphatase activity, and enhancing mineralization. The copper-dependent activation of lysyl oxidase (which cross-links bone collagen) and SOD (which protects osteoblasts from oxidative damage) may contribute to these effects.
Lung Fibrosis. Gene expression profiling indicates that GHK-Cu downregulates pro-fibrotic genes implicated in pulmonary fibrosis, including TGF-beta1 and various collagen-degrading enzymes. This anti-fibrotic gene signature has generated interest in GHK-Cu as a research tool for studying fibrotic diseases.
Neuroprotection. Emerging research suggests neuroprotective effects through antioxidant enzyme induction, anti-inflammatory modulation in neural tissue, and potential effects on neurotrophin expression.
GHK-Cu vs BPC-157
GHK-Cu and BPC-157 are both studied in tissue repair contexts but operate through entirely different mechanisms. GHK-Cu works primarily through copper-dependent metalloenzyme activation and broad transcriptional reprogramming affecting 4,000+ genes. BPC-157 works through NO system modulation, specific growth factor upregulation (VEGF, FGF, EGF), and FAK-paxillin pathway activation. Their evidence bases are also distinct: GHK-Cu has strong support in skin, ECM, and gene expression studies, while BPC-157 has extensive preclinical data in GI, tendon, and vascular models. The different mechanisms suggest potential complementarity in combination research.
Practical Research Notes
GHK-Cu is available from MiPeptidos as lyophilized powder at 99%+ purity. The reconstituted solution has a characteristic blue color due to the copper(II) complex. Store lyophilized at -20°C. Reconstitute with bacteriostatic water and store at 2–8°C.
Disclaimer
For research purposes only. Not for human consumption.